Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) - PubMed (original) (raw)
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)
K Forslind et al. Ann Rheum Dis. 2004 Sep.
Abstract
Objective: To investigate the role of anti-cyclic citrullinated peptide antibody (anti-CCP) for the prediction of radiological outcome in patients with early rheumatoid arthritis.
Methods: Anti-CCP was assessed at baseline in 379 patients with early rheumatoid arthritis (disease duration <1 year). Radiological joint damage and progression were assessed by Larsen score after two years of follow up (end point) and used as outcome variables. The prognostic value of anti-CCP and other demographic and disease related baseline variables were assessed by univariate and multivariate analyses, including calculation of odds ratios (OR), predictive values, and multiple logistic regression models.
Results: The presence of anti-CCP was associated with significantly higher Larsen score both at baseline and at end point. Univariate predictor analysis showed that anti-CCP had the highest significant OR for radiological joint damage and progression after baseline Larsen score, followed by rheumatoid factor, erythrocyte sedimentation rate (ESR), C reactive protein, age, smoking status, and sex. In stepwise multiple regression analyses, baseline Larsen score, anti-CCP, and ESR were selected as significant independent predictors of the radiological outcomes.
Conclusions: There is good evidence for an association of anti-CCP with radiological joint changes in rheumatoid arthritis. Anti-CCP is an independent predictor of radiological damage and progression. Though prediction in early rheumatoid arthritis is still far from perfect, the use of anti-CCP in clinical practice should make it easier for rheumatologists to reach judicious treatment decisions.
Similar articles
- Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S. Berglin E, et al. Ann Rheum Dis. 2006 Apr;65(4):453-8. doi: 10.1136/ard.2005.041376. Epub 2005 Sep 21. Ann Rheum Dis. 2006. PMID: 16176994 Free PMC article. - Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
Kaltenhäuser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Häntzschel H, Wagner U. Kaltenhäuser S, et al. Rheumatology (Oxford). 2007 Jan;46(1):100-4. doi: 10.1093/rheumatology/kel052. Epub 2006 May 25. Rheumatology (Oxford). 2007. PMID: 16728439 - The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S. Serdaroğlu M, et al. Rheumatol Int. 2008 Aug;28(10):965-70. doi: 10.1007/s00296-008-0570-3. Epub 2008 Apr 17. Rheumatol Int. 2008. PMID: 18418600 Free PMC article. - The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
Reneses S, González-Escribano MF, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A. Reneses S, et al. J Rheumatol. 2009 Jun;36(6):1143-9. doi: 10.3899/jrheum.081075. Epub 2009 May 1. J Rheumatol. 2009. PMID: 19411391 - Genetic influences modulating the radiological severity of rheumatoid arthritis.
Marinou I, Maxwell JR, Wilson AG. Marinou I, et al. Ann Rheum Dis. 2010 Mar;69(3):476-82. doi: 10.1136/ard.2009.117721. Epub 2010 Feb 2. Ann Rheum Dis. 2010. PMID: 20124360 Review.
Cited by
- A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes.
Karthikeyan K, Barker K, Tang Y, Kahn P, Wiktor P, Brunner A, Knabben V, Takulapalli B, Buckner J, Nepom G, LaBaer J, Qiu J. Karthikeyan K, et al. Mol Cell Proteomics. 2016 Jul;15(7):2324-37. doi: 10.1074/mcp.M115.057661. Epub 2016 May 2. Mol Cell Proteomics. 2016. PMID: 27141097 Free PMC article. - Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.
Martin-Mola E, Balsa A, García-Vicuna R, Gómez-Reino J, González-Gay MA, Sanmartí R, Loza E. Martin-Mola E, et al. Rheumatol Int. 2016 Aug;36(8):1043-63. doi: 10.1007/s00296-016-3506-3. Epub 2016 Jun 6. Rheumatol Int. 2016. PMID: 27271502 Review. - PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
Suzuki T, Ikari K, Yano K, Inoue E, Toyama Y, Taniguchi A, Yamanaka H, Momohara S. Suzuki T, et al. PLoS One. 2013;8(4):e61045. doi: 10.1371/journal.pone.0061045. Epub 2013 Apr 8. PLoS One. 2013. PMID: 23577190 Free PMC article. - Obesity and the Development of Arthritis Among Adults in the United States Using NHANES Data.
Baah E, Kohlmeier M. Baah E, et al. Clin Med Insights Arthritis Musculoskelet Disord. 2024 Jul 27;17:11795441241264820. doi: 10.1177/11795441241264820. eCollection 2024. Clin Med Insights Arthritis Musculoskelet Disord. 2024. PMID: 39091588 Free PMC article. - A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis.
Taylor P, Gartemann J, Hsieh J, Creeden J. Taylor P, et al. Autoimmune Dis. 2011;2011:815038. doi: 10.4061/2011/815038. Epub 2011 Sep 11. Autoimmune Dis. 2011. PMID: 21915375 Free PMC article.
References
- Arthritis Rheum. 2000 Jan;43(1):155-63 - PubMed
- Arthritis Rheum. 2002 Feb;46(2):357-65 - PubMed
- Arthritis Rheum. 2000 Aug;43(8):1831-5 - PubMed
- Rheumatology (Oxford). 2000 Sep;39(9):939-49 - PubMed
- Rheumatology (Oxford). 2000 Sep;39(9):1031-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous